Related Experiment Video
Updated: Jun 10, 2026

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia
Published on: May 21, 2010
iPatax: a Tablet-based Tool for Quantitative Assessment of Cerebellar Ataxia
Takahiro Nagai1, Shingo Koide1, Tomohiko Ishihara2
1Department of Neurology, Brain Research Institute, Niigata University, 1- 757 Asahimachi-dori, Chuo-ku, Niigata, 951-8585, Japan.
None:
The clinical severity of cerebellar ataxia is still assessed primarily using ordinal rating scales, and continuous quantitative measures are still limited. In this context, we have developed iPatax, an iPad®-based application, as a quantitative and objective tool for assessment of cerebellar motor dysfunction. Finger movements were recorded in 27 controls and 28 patients with cerebellar ataxia during three target-following tasks: non-continuous linear, non-continuous circular, and continuous circular movements. In the controls, the coefficient of variation of velocity (CVV) during non-continuous linear movements and the average distance from the target trajectory (AD) during non-continuous circular movement both improved over repeated trials, consistent with learning-related changes, and were prioritized as candidate metrics. Both metrics differentiated patients with cerebellar ataxia from controls (AUCs = 0.853 and 0.918, respectively). In the patients, CVV during non-continuous linear movement correlated significantly with both the total Scale for the Assessment and Rating of Ataxia (SARA) score and the upper-limb subscore (total SARA: rS = 0.50; upper-limb subscore: rS = 0.51), whereas AD during non-continuous circular movements correlated with the total SARA score but not with the upper-limb subscore (total SARA: rS = 0.44; upper-limb subscore: rS = 0.063). These findings suggest that, as a widely available tablet device, iPatax can capture and quantify clinically relevant temporal and trajectory-related aspects of cerebellar motor dysfunction. This approach may supplement current ordinal rating scales in clinical and research settings.
